CN105925518A - Olefin production - Google Patents
Olefin production Download PDFInfo
- Publication number
- CN105925518A CN105925518A CN201610104399.7A CN201610104399A CN105925518A CN 105925518 A CN105925518 A CN 105925518A CN 201610104399 A CN201610104399 A CN 201610104399A CN 105925518 A CN105925518 A CN 105925518A
- Authority
- CN
- China
- Prior art keywords
- cell
- fatty acid
- acid
- enzyme
- olet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001336 alkenes Chemical class 0.000 title claims abstract description 55
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 title claims abstract description 34
- 238000004519 manufacturing process Methods 0.000 title abstract description 9
- 102000004190 Enzymes Human genes 0.000 claims abstract description 69
- 108090000790 Enzymes Proteins 0.000 claims abstract description 69
- 239000000194 fatty acid Substances 0.000 claims abstract description 68
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 64
- 229930195729 fatty acid Natural products 0.000 claims abstract description 64
- 102000004316 Oxidoreductases Human genes 0.000 claims abstract description 27
- 108090000854 Oxidoreductases Proteins 0.000 claims abstract description 27
- 150000004666 short chain fatty acids Chemical class 0.000 claims abstract description 18
- 206010064571 Gene mutation Diseases 0.000 claims abstract description 7
- 230000000813 microbial effect Effects 0.000 claims abstract description 5
- 210000004027 cell Anatomy 0.000 claims description 106
- 150000004665 fatty acids Chemical class 0.000 claims description 63
- 238000000034 method Methods 0.000 claims description 40
- 230000008859 change Effects 0.000 claims description 17
- 108090000623 proteins and genes Proteins 0.000 claims description 17
- 244000005700 microbiome Species 0.000 claims description 15
- 239000005977 Ethylene Substances 0.000 claims description 13
- 230000009467 reduction Effects 0.000 claims description 11
- 101710088194 Dehydrogenase Proteins 0.000 claims description 10
- 230000033228 biological regulation Effects 0.000 claims description 10
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 claims description 9
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 8
- 230000004133 fatty acid degradation Effects 0.000 claims description 8
- 102000002932 Thiolase Human genes 0.000 claims description 7
- 108060008225 Thiolase Proteins 0.000 claims description 7
- 108010074122 Ferredoxins Proteins 0.000 claims description 6
- 238000011069 regeneration method Methods 0.000 claims description 6
- ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 claims description 6
- 101710192343 NADPH:adrenodoxin oxidoreductase, mitochondrial Proteins 0.000 claims description 5
- 102100036777 NADPH:adrenodoxin oxidoreductase, mitochondrial Human genes 0.000 claims description 5
- 101710104207 Probable NADPH:adrenodoxin oxidoreductase, mitochondrial Proteins 0.000 claims description 5
- 230000008034 disappearance Effects 0.000 claims description 5
- 230000008929 regeneration Effects 0.000 claims description 5
- 108090000417 Oxygenases Proteins 0.000 claims description 4
- 102000004020 Oxygenases Human genes 0.000 claims description 4
- 238000012239 gene modification Methods 0.000 claims description 4
- 230000005017 genetic modification Effects 0.000 claims description 4
- 235000013617 genetically modified food Nutrition 0.000 claims description 4
- 108010060537 putidaredoxin Proteins 0.000 claims description 4
- 108010043434 putidaredoxin reductase Proteins 0.000 claims description 4
- 102000003960 Ligases Human genes 0.000 claims description 2
- 108090000364 Ligases Proteins 0.000 claims description 2
- 210000003527 eukaryotic cell Anatomy 0.000 claims description 2
- 108010087894 Fatty acid desaturases Proteins 0.000 claims 1
- 102000009114 Fatty acid desaturases Human genes 0.000 claims 1
- 230000035772 mutation Effects 0.000 abstract description 2
- 102000034356 gene-regulatory proteins Human genes 0.000 abstract 1
- 108091006104 gene-regulatory proteins Proteins 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 63
- 238000006243 chemical reaction Methods 0.000 description 53
- 239000000047 product Substances 0.000 description 34
- 239000000758 substrate Substances 0.000 description 34
- 238000007254 oxidation reaction Methods 0.000 description 28
- 230000003647 oxidation Effects 0.000 description 27
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N pentanoic acid group Chemical group C(CCCC)(=O)O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 25
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 25
- 230000000694 effects Effects 0.000 description 24
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical group CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 24
- 108090000765 processed proteins & peptides Proteins 0.000 description 23
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 22
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical group CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 19
- 229920001184 polypeptide Polymers 0.000 description 19
- 102000004196 processed proteins & peptides Human genes 0.000 description 19
- 241000588724 Escherichia coli Species 0.000 description 18
- 238000013459 approach Methods 0.000 description 17
- 239000003960 organic solvent Substances 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 230000015572 biosynthetic process Effects 0.000 description 15
- 125000003275 alpha amino acid group Chemical group 0.000 description 14
- 238000006114 decarboxylation reaction Methods 0.000 description 14
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical group CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 14
- 108020004707 nucleic acids Proteins 0.000 description 14
- 102000039446 nucleic acids Human genes 0.000 description 14
- 150000007523 nucleic acids Chemical class 0.000 description 14
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 14
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 13
- 239000002773 nucleotide Substances 0.000 description 13
- 125000003729 nucleotide group Chemical group 0.000 description 13
- 235000001014 amino acid Nutrition 0.000 description 12
- 150000001413 amino acids Chemical class 0.000 description 12
- 238000006555 catalytic reaction Methods 0.000 description 12
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 12
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 12
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 239000002904 solvent Substances 0.000 description 11
- 239000004711 α-olefin Substances 0.000 description 11
- -1 acyclic olefin Chemical class 0.000 description 10
- 239000007864 aqueous solution Substances 0.000 description 10
- 229910052799 carbon Inorganic materials 0.000 description 10
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical group CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 10
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 10
- 229940005605 valeric acid Drugs 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 235000021355 Stearic acid Nutrition 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 9
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 9
- 239000007800 oxidant agent Substances 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 239000008117 stearic acid Substances 0.000 description 9
- 239000000872 buffer Substances 0.000 description 8
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- CZWSZZHGSNZRMW-UHFFFAOYSA-N 1,2-dibromobutane Chemical compound CCC(Br)CBr CZWSZZHGSNZRMW-UHFFFAOYSA-N 0.000 description 7
- 108010023922 Enoyl-CoA hydratase Proteins 0.000 description 7
- 102000011426 Enoyl-CoA hydratase Human genes 0.000 description 7
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 7
- 101150053185 P450 gene Proteins 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 230000001419 dependent effect Effects 0.000 description 7
- 125000004050 enoyl group Chemical group 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- XFNJYAKDBJUJAJ-UHFFFAOYSA-N 1,2-dibromopropane Chemical group CC(Br)CBr XFNJYAKDBJUJAJ-UHFFFAOYSA-N 0.000 description 6
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 6
- 108010020056 Hydrogenase Proteins 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 238000001212 derivatisation Methods 0.000 description 6
- 238000000502 dialysis Methods 0.000 description 6
- 238000000769 gas chromatography-flame ionisation detection Methods 0.000 description 6
- 238000009396 hybridization Methods 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 229960002446 octanoic acid Drugs 0.000 description 6
- 230000001590 oxidative effect Effects 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 102100039702 Alcohol dehydrogenase class-3 Human genes 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 5
- 239000005516 coenzyme A Substances 0.000 description 5
- 229940093530 coenzyme a Drugs 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 108010051015 glutathione-independent formaldehyde dehydrogenase Proteins 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 239000000376 reactant Substances 0.000 description 5
- 230000027756 respiratory electron transport chain Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 241000235070 Saccharomyces Species 0.000 description 4
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
- MUCRYNWJQNHDJH-OADIDDRXSA-N Ursonic acid Chemical compound C1CC(=O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C MUCRYNWJQNHDJH-OADIDDRXSA-N 0.000 description 4
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 4
- 125000002252 acyl group Chemical group 0.000 description 4
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 4
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- KWKAKUADMBZCLK-UHFFFAOYSA-N 1-octene Chemical compound CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 208000035126 Facies Diseases 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 150000004675 formic acid derivatives Chemical class 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 150000002460 imidazoles Chemical class 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 229920002401 polyacrylamide Polymers 0.000 description 3
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000001172 regenerating effect Effects 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 description 2
- ADOBXTDBFNCOBN-UHFFFAOYSA-N 1-heptadecene Chemical compound CCCCCCCCCCCCCCCC=C ADOBXTDBFNCOBN-UHFFFAOYSA-N 0.000 description 2
- 102000052553 3-Hydroxyacyl CoA Dehydrogenase Human genes 0.000 description 2
- 108700020831 3-Hydroxyacyl-CoA Dehydrogenase Proteins 0.000 description 2
- VNLOLXSJMINBIS-UHFFFAOYSA-N 3-Methyl-2-butenoyl-2,2':5',2''-Terthiophene-5-methanol, Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O1 VNLOLXSJMINBIS-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000194107 Bacillus megaterium Species 0.000 description 2
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 2
- 241000186216 Corynebacterium Species 0.000 description 2
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 2
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000588722 Escherichia Species 0.000 description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 2
- 101150071111 FADD gene Proteins 0.000 description 2
- 241000589236 Gluconobacter Species 0.000 description 2
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 2
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 101100390398 Mus musculus Ptk2 gene Proteins 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- 241001443590 Naganishia albida Species 0.000 description 2
- 239000005643 Pelargonic acid Substances 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- 241000235648 Pichia Species 0.000 description 2
- 241000589776 Pseudomonas putida Species 0.000 description 2
- 241000235346 Schizosaccharomyces Species 0.000 description 2
- 244000300264 Spinacia oleracea Species 0.000 description 2
- 235000009337 Spinacia oleracea Nutrition 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000006184 cosolvent Substances 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000006356 dehydrogenation reaction Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 150000003278 haem Chemical class 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000001261 hydroxy acids Chemical class 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- UQDUPQYQJKYHQI-UHFFFAOYSA-N methyl laurate Chemical compound CCCCCCCCCCCC(=O)OC UQDUPQYQJKYHQI-UHFFFAOYSA-N 0.000 description 2
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 2
- 238000007833 oxidative deamination reaction Methods 0.000 description 2
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical group CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 239000005968 1-Decanol Substances 0.000 description 1
- CYNYIHKIEHGYOZ-UHFFFAOYSA-N 1-bromopropane Chemical compound CCCBr CYNYIHKIEHGYOZ-UHFFFAOYSA-N 0.000 description 1
- BKOOMYPCSUNDGP-UHFFFAOYSA-N 2-methylbut-2-ene Chemical group CC=C(C)C BKOOMYPCSUNDGP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- 102100026105 3-ketoacyl-CoA thiolase, mitochondrial Human genes 0.000 description 1
- OXDRRSIWCCBLOE-UHFFFAOYSA-N 3-methylbutanoic acid Chemical compound CC(C)CC(O)=O.CC(C)CC(O)=O OXDRRSIWCCBLOE-UHFFFAOYSA-N 0.000 description 1
- QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 102100026026 Acyl-CoA synthetase short-chain family member 3, mitochondrial Human genes 0.000 description 1
- 241000611270 Alcanivorax borkumensis Species 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000995051 Brenda Species 0.000 description 1
- 101100400452 Caenorhabditis elegans map-2 gene Proteins 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 102100021973 Carbonyl reductase [NADPH] 1 Human genes 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 102000005870 Coenzyme A Ligases Human genes 0.000 description 1
- 108010002154 Cortisone Reductase Proteins 0.000 description 1
- 102100030497 Cytochrome c Human genes 0.000 description 1
- 108010075031 Cytochromes c Proteins 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 150000000782 D-glucoses Chemical class 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000221420 Filobasidium uniguttulatum Species 0.000 description 1
- 108090000698 Formate Dehydrogenases Proteins 0.000 description 1
- 102000002794 Glucosephosphate Dehydrogenase Human genes 0.000 description 1
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
- 102000000587 Glycerolphosphate Dehydrogenase Human genes 0.000 description 1
- 108010041921 Glycerolphosphate Dehydrogenase Proteins 0.000 description 1
- 101000633503 Homo sapiens Nuclear receptor subfamily 2 group E member 1 Proteins 0.000 description 1
- 108090001042 Hydro-Lyases Proteins 0.000 description 1
- 102000004867 Hydro-Lyases Human genes 0.000 description 1
- 102000012011 Isocitrate Dehydrogenase Human genes 0.000 description 1
- 108010075869 Isocitrate Dehydrogenase Proteins 0.000 description 1
- 108010009384 L-Iditol 2-Dehydrogenase Proteins 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 108010011449 Long-chain-fatty-acid-CoA ligase Proteins 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 108010026217 Malate Dehydrogenase Proteins 0.000 description 1
- 102000013460 Malate Dehydrogenase Human genes 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- 102100029534 Nuclear receptor subfamily 2 group E member 1 Human genes 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 101710116435 Outer membrane protein Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000190932 Rhodopseudomonas Species 0.000 description 1
- 108050008280 Shikimate dehydrogenase Proteins 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- 241000222050 Vanrija humicola Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 241000235013 Yarrowia Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical class [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000002210 biocatalytic effect Effects 0.000 description 1
- 239000002551 biofuel Substances 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 150000001924 cycloalkanes Chemical class 0.000 description 1
- 150000001925 cycloalkenes Chemical class 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000012527 feed solution Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 125000004836 hexamethylene group Chemical class [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- PANJMBIFGCKWBY-UHFFFAOYSA-N iron tricyanide Chemical compound N#C[Fe](C#N)C#N PANJMBIFGCKWBY-UHFFFAOYSA-N 0.000 description 1
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000028744 lysogeny Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012269 metabolic engineering Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 125000005473 octanoic acid group Chemical group 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- HUPQYPMULVBQDL-UHFFFAOYSA-N pentanoic acid Chemical compound CCCCC(O)=O.CCCCC(O)=O HUPQYPMULVBQDL-UHFFFAOYSA-N 0.000 description 1
- 108010023506 peroxygenase Proteins 0.000 description 1
- 108010085336 phosphoribosyl-AMP cyclohydrolase Proteins 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000135 prohibitive effect Effects 0.000 description 1
- 230000007026 protein scission Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000009418 renovation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- NCPXQVVMIXIKTN-UHFFFAOYSA-N trisodium;phosphite Chemical class [Na+].[Na+].[Na+].[O-]P([O-])[O-] NCPXQVVMIXIKTN-UHFFFAOYSA-N 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P5/00—Preparation of hydrocarbons or halogenated hydrocarbons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0065—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0095—Oxidoreductases (1.) acting on iron-sulfur proteins as donor (1.18)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P5/00—Preparation of hydrocarbons or halogenated hydrocarbons
- C12P5/02—Preparation of hydrocarbons or halogenated hydrocarbons acyclic
- C12P5/026—Unsaturated compounds, i.e. alkenes, alkynes or allenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01035—3-Hydroxyacyl-CoA dehydrogenase (1.1.1.35)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/99—Oxidoreductases acting on the CH-OH group of donors (1.1) with other acceptors (1.1.99)
- C12Y101/9901—Glucose dehydrogenase (acceptor) (1.1.99.10)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
- C12Y102/01—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
- C12Y102/01043—Formate dehydrogenase (NADP+) (1.2.1.43)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y103/00—Oxidoreductases acting on the CH-CH group of donors (1.3)
- C12Y103/99—Oxidoreductases acting on the CH-CH group of donors (1.3) with other acceptors (1.3.99)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
- C12Y111/02—Oxidoreductases acting on a peroxide as acceptor (1.11) with H2O2 as acceptor, one oxygen atom of which is incorporated into the product (1.11.2)
- C12Y111/02004—Fatty-acid peroxygenase (1.11.2.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y118/00—Oxidoreductases acting on iron-sulfur proteins as donors (1.18)
- C12Y118/01—Oxidoreductases acting on iron-sulfur proteins as donors (1.18) with NAD+ or NADP+ as acceptor (1.18.1)
- C12Y118/01005—Putidaredoxin—NAD+ reductase (1.18.1.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y120/00—Oxidoreductases acting on phosphorus or arsenic in donors (1.20)
- C12Y120/01—Oxidoreductases acting on phosphorus or arsenic in donors (1.20) with NAD+ or NADP+ as acceptor (1.20.1)
- C12Y120/01001—Phosphonate dehydrogenase (1.20.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
- C12Y203/01016—Acetyl-CoA C-acyltransferase (2.3.1.16)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/01—Hydro-lyases (4.2.1)
- C12Y402/01017—Enoyl-CoA hydratase (4.2.1.17), i.e. crotonase
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The invention relates to olefin production and provides a microbial cell capable of producing at least one terminal olefin from at least one short chain fatty acid, wherein the cell is genetically modified to comprise-at least a first gene mutation that increases an enzyme selected from the CYP152 perhydrolase family (E) compared to a wild-type cell1) And-At least a second genetic mutation that increases at least one NAD (P) + oxidoreductase (E) compared to wild-type cells2) And the expression of the corresponding regulatory protein, wherein the short chain fatty acid is C4-C10A fatty acid.
Description
Technical field
The present invention relates to produce cell and/or the biotechnology side of at least one alkene from least one fatty acid
Method.Specifically, described alkene is at least one terminal olefin produced from short-chain fatty acid.
Background technology
Have studied multiple method and biomass are changed into sustainable substitute valuable that can serve as oil
Chemical compound.Oil (chemical structural units and the main source of transport fuel) is consumed continuously, and price
Always fluctuate.Accordingly, it would be desirable to find alternative energy source.A kind of such energy is alkene.
Such as, short chain and middle chain alpha-olefin act not only as bio-fuel, and serve as constitutional unit.Specifically,
Alkene can be widely used for preparing lubricant, polymer and detergent.
Fatty acid is the preferred initiation material for producing alkene, because they contain the carbon being in low-oxidation-state.Fat
Acid the most often can obtain with low price from natural resources (such as fat) in a large number.
Being chemical in nature producing current methods used in alkene from fatty acid, wherein alpha-olefin is from saturated nothing
Branched fatty acid (>=C11) formed.That these methods it is frequently necessary to costliness and/or poisonous catalyst based on metal and high temperature
(>130℃)。
In 2011, Rude et al. reports employing P450 monooxygenase OleT will be without branch saturated long-chain C18-and C16-
Fatty acid (stearic acid and Palmic acid) first directly enzymatic decarboxylation becomes alpha-olefin.This catalyst uses H2O2As oxidant via
Its peroxide bypass is worked, and this can avoid the demand to Native Oxide reduction gametophyte.Belcher, J., et al.,
2014 crystal structures then disclosing OleT, and substrate spectrum is extended to C12-fatty acid (lauric acid).But, H2O2
Purposes as oxidant has several security concern, not only breaks up the mechanism that it is possibly present therein, and is unstable
Fixed.H is constantly added in reactant mixture2O2Need also can increase the cost of reaction, and be inconvenient.Therefore,
Available biological technique method is inefficient, and can not be with low-cost production height yield.Therefore, there is a need in the art for changing
The biological technique method producing alkene from Renewable resource entered.
Summary of the invention
The cell of any aspect according to the present invention produces the biotechnological ways of alkene by providing from short-chain fatty acid
Solve the problems referred to above.Specifically, provide by least having C according to the cell of any aspect of the present invention4-C10Chain length
The short chain of degree is the new enzyme cascade of living things catalysis synthesis terminal olefin without the oxidative deamination of branch's satisfied fatty acid, wherein said carefully
Born of the same parents need not H2O2.The cascade of described new enzyme includes decarboxylic reaction, and it is H2O2-dependent/non-dependent, and can be by least one P450
Monooxygenase is catalyzed.Specifically, described cell expresses enzyme, such as OleT, and it can optimize living things catalysis system to use
Decarboxylic reaction produces at least one alkene from short-chain fatty acid.
In one aspect of the invention, it is provided that at least one terminal olefin can be produced from least one short-chain fatty acid
Microbial cell, wherein said cell through genetic modification to comprise
-at least the first gene mutation, it increases compared with wild-type cell crosses oxygenase selected from CYP152
(peroxygenase) enzyme (E of family1) expression, and
-at least the second gene mutation, it increases at least one NAD (P)+oxidoreductase (E compared with wild-type cell2)
With the expression of corresponding regulation albumen,
Wherein said short-chain fatty acid is C4-C10Fatty acid.
Different from the general chemical catalysis route being frequently used for producing alkene, the method according to any aspect of the present invention can
To use full cell or the enzyme of separation.This allows to carry out under mild reaction conditions described method, is achieved in having minimum giving up
The sustainable method of thing discharge.This is a unexpected result, because prior art (Fujishiro T., 2007 Hes
Matsunaga I., 2002) report, P450 reductase system (such as ferredoxin and ferredoxin reductase) is no
Support P450BSβAnd P450SPαActivity.
Additionally, allow from the short-chain fatty acid large-scale production alkene as substrate according to the cell of any aspect of the present invention
Hydrocarbon.This can see in instances, in the illustration being described, uses the concentration of substrate of 10mM to produce the alkene of correspondence.This is one
Individual unexpected result, because the substrate (such as stearic acid) that presently available olefins production indicates maximum 1mM converts
Become various alkene.
According to another aspect of the present invention, it is provided that produce at least one terminal olefin from least one short-chain fatty acid
Method.
The method of any aspect according to the present invention has the further advantage that, such as it uses O2As oxidant, it makes
The method is than use H known in the art2O2Method as oxidant is more effective；The method allows to carry out from Renewable resource
Electron transfer, and also cause significantly high olefin yield according to the method for any aspect of the present invention.
According to another aspect of the present invention, it is provided that be used for producing at least one according to the cell of any aspect of the present invention
Plant the purposes of terminal olefin.
The cell of any aspect according to the present invention can directly use free fatty alternative fats acid thioester
As substrate, it is probably favourable for metabolic engineering, because fatty acid can be more rich.Additionally,
It is typically used as in the cell (such as, escherichia coli (E. coli)) of Microbial cell factories can more easily handling theirs
Abundance and composition.
Thus, the cell of any aspect according to the present invention with P450 decarboxylation of fatty acids mechanism can keep through engineering
It is transformed into the great potential of biological terminal olefin production system.Additionally, the cell according to any aspect of the present invention can be for decarboxylation
Reaction provides living things catalysis system (> the 100 mg L optimized-1), and substrate spectrum is extended to short-chain fatty acid.
Terminal olefin can also be referred to as terminal ethylenic hydrocarbon, and it represents that the end in carbochain contains at least one carbon-to-carbon pair
The unsaturated hydrocarbons of key.This C-C double bond can be at beginning (α) place of hydrocarbon chain or end (γ) place.Simplest acyclic olefin is (only
There is a double bond and not there is other functional group) can have formula CnH2n.In another example, terminal olefin can also
Comprise other functional group.The terminal olefin of any aspect according to the present invention can comprise and substrate short-chain fatty acid same number
Carbon atom as the number of carbon atom.Such as, if substrate is butanoic acid, the terminal olefin of formation can be propylene.Similarly,
If substrate is valeric acid (valeric acid/ pentanoic acid), the terminal olefin of formation can be butylene；If the end
Thing is caproic acid (caproic acid/ hexanoic acid), and the terminal olefin of formation can be amylene；If substrate is enanthic acid
(enanthic acid/ heptanoic acid), the terminal olefin of formation can be hexene；If substrate is octanoic acid
(caprylic acid/ octanoic acid), the terminal olefin of formation can be heptene；If substrate is n-nonanoic acid
(pelargonic acid/ nonanoic acid), the terminal olefin of formation can be octene；If substrate is capric acid
(capric acid/ decanoic acid), the terminal olefin of formation can be nonene etc..In an example, use in reality
New method shown in example, can measure the alkene such as propylene and/or 1-butylene produced from various fatty acids.
The term that uses in the present invention " short-chain fatty acid ' represent the fatty acid with the aliphatic tail less than 10 carbon
Subgroup.Described fatty acid can be saturated, undersaturated, side chain or unbranched fatty acid.Specifically, according to the present invention's
The short-chain fatty acid that any aspect uses can be selected from: propanoic acid, butanoic acid (butyric acid/ butanoic acid), valeric acid
(valeric acid/ pentanoic acid), caproic acid (caproic acid/ hexanoic acid), enanthic acid
(enanthic acid/ heptanoic acid), octanoic acid (caprylic acid/ octanoic acid), n-nonanoic acid
(pelargonic acid/ nonanoic acid), capric acid (capric acid/ decanoic acid) etc..More specifically,
The short-chain fatty acid that any aspect according to the present invention uses can be C2-C22Fatty acid.Even more specifically, described fatty acid
Can be C4- C10Fatty acid.In an example, described fatty acid can be selected from: acetic acid, propanoic acid, isopropylformic acid. (2-methyl-prop
Acid), butanoic acid, isovaleric acid (3 Methylbutanoic acid), valeric acid (valeric acid) etc..
The cell of any aspect according to the present invention can represent the microbial cell of wide scope.Specifically, described cell
Can be selected from following protokaryon or the eukaryotic cell such as low: Rhodopseudomonas (Pseudomonas), corynebacterium
(Corynebacterium), bacillus (Bacillus) and Escherichia (Escherichia).In an example,
Described cell can be escherichia coli (Escherichia coli).In another example, described cell can be that low grade is true
Core is biological, such as from Saccharomyces (Saccharomyces), mycocandida (Candida), pichia (Pichia),
Schizosaccharomyces (Schizosaccharomyces) and ascomycetous yeast belong to the fungus of (Yarrowia), particularly saccharomyces cerevisiae
(Saccharomyces cerevisiae).Described cell can be the cell separated, in other words, the pure culture of single bacterial strain
Thing, maybe can comprise the mixture of at least two bacterial strain.Cell relevant in biotechnology is obtained commercially, such as, derive from U.S.
State's Type Tissue Collection (American Type Culture Collection, ATCC) or Germany's microorganism and cell
Culture collection center (German Collection of Microorganisms and Cell Cultures, DSMZ).With
Granule in preservation and change cell is available from prior art, such as Sambrook/Fritsch/Maniatis (1989).
The phrase " wild type " used herein in connection with cell or microorganism can represent such cell: its have in
The composition of genome of the form that field finds natively.This term can apply to full cell and individual gene.Term is " wild
Raw type " the most do not include such cell or such gene, wherein people have used recombination method to change at least in part
Gene order.
Any enzyme that any aspect according to the present invention uses can be the enzyme separated.Specifically, appointing according to the present invention
The enzyme where face uses can with activated state and the necessary all cofactors of the activity having it, substrate, complementary and/
Or use in the presence of the polypeptide of reactivity or the factor.Term used herein " separation " refers to, with it the most natively
The cell existed is compared, and is enriched with target enzyme.Described enzyme can be enriched with by sds polyacrylamide electrophoresis and/or determination of activity.
Such as, target enzyme can account for all polypeptide of being present in goods more than 5%, 10%, 20%, 50%, 75%, 80%, 85%, 90%,
95% or 99%, as after dyeing with Coomassie Blue dye, visual inspection polyacrylamide gel judges.
Cell and/or enzyme that any aspect according to the present invention uses can be recombinants.Term used herein " weight
Group body " represent a kind of molecule or by such molecule encoding, particularly polypeptide or nucleic acid, it is because of without existing natively, and
It is engineered result, or represents the cell comprising recombinant molecule.Such as, if nucleic acid molecules comprises such promoter,
Then nucleic acid molecules is restructuring: the sequence that described promoter is functionally catalyzed active polypeptide with coding is connected, and described startup
Son passes through engineered so that described catalysis active polypeptide is corresponding wild with comprise original unchanged nucleic acid molecules
Peptide level in type cell compares process LAN.
Whether nucleic acid molecules, polypeptide (more specifically, enzyme) that any aspect according to the present invention uses are that recombinant differs
Surely its expression is implied.But, in an example, one or more restructuring used according to any aspect of the present invention
Nucleic acid molecules, polypeptide or enzyme can be with process LAN.Term used herein " process LAN " refers to, each peptide species encoding or expressing
Expression or activity higher than not used for increase express genetic modification in the presence of under the same conditions at described cell
In (such as in various wild-type cells) be usually present.Those skilled in the art know numerous modes realizing process LAN.
Such as, nucleic acid molecules or the coding of process LAN want the polypeptide of process LAN or the nucleic acid molecules of enzyme can be placed in the startup of strong induction type
Under the control of son (such as lac promoter).Prior art describes the standard plasmid that may be used for this purpose, such as with pET-3a
For the pET carrier system (commercially available from Novagen) represented.By quantitative PCR reaction (in the case of nucleic acid molecules),
Sds polyacrylamide electrophoresis, western blotting or compare determination of activity (in the case of polypeptide), it may be determined that nucleic acid or many
Whether peptide is over-expressed.Genetic modification can point to and cause enzymatic activity and/or choosing under condition of culture that is that select and/or that differentiate
The change of selecting property transcribe modification, translation modify and/or post translational modification.Thus, in the different instances of the present invention, in order to more
Function effectively, microorganism can comprise one or more gene delection.Gene delection can be lacked by mutability gene
Mistake scheme completes, and/or starts from the mutant expressed or do not express of one or more having in these enzymes of minimizing,
And/or other method well known by persons skilled in the art.
Enzyme (the E crossing oxygenase family selected from CYP152 that any aspect according to the present invention uses1) can be cell color
The ingredient (Malca et al., 2011) of the superfamily of element P450 enzyme (CYP).Generally, P450 enzyme uses one or more oxygen
Change reduction partner protein and two electronics are transferred to heme iron reaction center for Dioxygen activation from NAD (P) H, then will
O2Atom insert their substrate.Enzyme in CYP152 crosses oxygenase family has been identified as exclusively using
H2O2As sole electron and oxygen donor.But, in the cell according to any aspect of the present invention, NAD (P)+oxidoreduction
Enzyme (E2) and corresponding regulation albumen can serve as the source of electronics and oxygen donor.This is favourable, because at low cost end
In the large-scale production of alkene, the application of a large amount of peroxide is cost prohibitive, and high H2O2Concentration can be gone out rapidly
Living organism catalyst.Therefore, NAD (P)+oxidoreductase (E2) and the application meeting originated as electronics of corresponding regulation albumen
The more cost-efficient micro-organisms of terminal olefin is provided.This can be explained further in 2014 at Liu et al..
Specifically, enzyme E1Can be selected from: CYPSPα(E1a)、CYPBSB (E1b) (EC 1.11.2.4) and OleT (E1c).More
Specifically, enzyme E1Can be OleT (E1c) or its variant.In an example, enzyme E1The sequence of ADW41779.1 can be comprised.
In an example, enzyme E1Can have 50% with SEQ ID NO:1,55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%,
95%, 98%, 100% sequence iden.
Technical staff can differentiate the side that may be used for realizing forming at least one terminal olefin from least one fatty acid
The possible sequence of the OleT of method.In an example, technical staff can use Liu et al., 2014, Rude M.A, 2011,
Schallmey, A., 2011, Fukada H., 1994, Belcher J., the disclosure in 2014 grades determines OleT
(E1c) structure and by OleT (E1c) introduce in suitable cell and determine the mode of described enzyme expression in described cell.
OleT is (with other H2O2Dependent enzyme reaction is compared) artificial electron's transfer system of higher yield can be caused.
The cell of any aspect according to the present invention can comprise second gene mutation, and it is increasing compared with wild-type cell
Add at least one enzyme, NAD (P)+oxidoreductase (E2) and the expression regulating albumen of correspondence.These enzymes belong to oxidation regulation
Albumen also accepts the oxidoreduction enzyme family of two electronics.Specifically, NAD (P)+oxidoreductase uses ferrum-sulfoprotein conduct
Electron donor also uses NAD+Or NADP+As electron acceptor.Hannemann et al. discloses and can serve as according to the present invention's
The enzyme E of any aspect2The different classes of list of oxidoreduction-medium.In an example, manually/" chemistry " oxidation is also
Electronics can be originated from reductase or electronics and is transferred to heme iron bunch by former medium.
More specifically, NAD (P)+oxidoreductase (EC 1.18.1.5) and corresponding albumen can be selected from:
(a) ferredoxin reductase (E2a) and ferredoxin；Or
(b) putidaredoxin reductase (E2b) and putidaredoxin (Schallmey, A., 2011).
Specifically, E2Can be CamA, and regulation albumen can be CamB.E2Can have 50% with SEQ ID:NO:2,
55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 98%, 100% sequence iden, and/or regulation albumen can be with SEQ
ID:NO:3 has 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 98%, 100% sequence iden.
In an example, in the cell according to any aspect of the present invention, E2It can be ferredoxin reductase
(E2a), wherein ferredoxin can also exist, and E2aCan functionally with E1Interact.Specifically, E1And E2
Source can be identical or different.In an example, E1And E2Can come from identical source, such as from Bo Ku island alkane eating bacteria
(Alcanivorax borkumensis) SK2 (accession number YP_691921).In this example, E2aPermissible with ferredoxin
It is respectively provided with accession number YP_691923 and YP_691920.
In another example, in the cell according to any aspect of the present invention, E2It can be putidaredoxin
Reductase (E2b), wherein putidaredoxin can also exist, and E2bCan functionally with E1Interact.One
In individual example, E2bCan come from deriving from the P450 of pseudomonas putida (Pseudomonas putida)camEnzyme system.For vacation
Monospore oxygen also reductase proteins, the amount of the enzyme of employing generally can be about 100-10,000 ca, 1000-5000 ca, 2000-
4000 ca or particularly 3000 ca.This ca is that putidaredoxin reductase is in the mediation iron cyanide oxidation to NADH
The unit of activity, and be defined as the NADH of 1 μm ol of every mg reductase oxidation per minute.
E2Be the most purified or separate recombiant protein or naturally occurring albumen.E2Sudden change can be passed through to improve
Its performance, such as carries out speed or its substrate specificity of electron transfer optimizing it.Measuring certainly of the reductase used
In definite character and the specific detail of mensuration of measurement object, but generally, described reductase will be with 0-1000 μM, 0.001-
The concentration of 100 μMs, 0.01-50 μM, 0.1-25 μM and particularly 1-10 μM exists.
The cell of any aspect according to the present invention comprises at least the 3rd gene mutation, itself and wild-type cell further
Compare and increase at least one enzyme (E that can regenerate cofactor3) expression.Specifically, E3Can regeneration of NAD (P) H.E3Can
Being can any enzyme of regeneration of NAD (P) H.Specifically, E3Can be to use NAD (P) as the dehydrogenation of electron acceptor
Enzyme/oxidoreductase (EC 1.1.1.X).More specifically, E3Can be to have in Brenda data base on February 24th, 2014
There is any enzyme of KEGG EC 1.1.1.X.Such as, E3Can be selected from: alcoholdehydrogenase, glycerol phosphate dehydrogenase, histidinol dehydrogenase
Enzyme, shikimate dehydrogenase, lactic acid dehydrogenase, 3-hydroxyaryl-CoA dehydrogenase, malic dehydrogenase, Isocitrate dehydrogenase,
Glucose-6-phosphate dehydrogenase, hydrogenlyase, HLADH, glucose dehydrogenase, amino acid dehydrogenase, sorbitol are de-
Hydrogen enzyme, 20-beta-hydroxysteroid dehydrogenase and formaldehyde dehydrogenase.Even more specifically, enzyme (E3) can be selected from: glucose dehydrogenation
Enzyme (E3a) (EC 1.1.99.10), phosphorous acid dehydrogenase (E3b) (EC 1.20.1.1) and hydrogenlyase (E3c) (EC
1.2.1.43), wherein glucose, phosphite and formates are used separately as reducing agent.Enzyme (E3) existence allow cofactor again
Raw, this makes the method producing alkene from fatty acid be self-sustained.Therefore need not by external energy introduce produce alkene be
In system.Therefore, can there iing at least enzyme E according to the cell of any aspect of the present invention1、E2And/or E3In the presence of without appoint
What extra power produces at least one alkene from fatty acid.
In an example, glucose dehydrogenase (E3a) can be the specific glucose dehydrogenase of NADP+-.Serve as Portugal
Grape glucocorticoid dehydrogenase (E3a) the biology in source unrestricted, and can be microorganism or higher organism, and microorganism is the thinnest
Bacterium, fungus and yeast are suitable.Such as, the microorganism of bacillus (Bacillus), particularly bacillus megaterium
(Bacillus megaterium) can be source.In another example, described source can be belonging to Cryptococcus
(Cryptococcus), Gluconobacter (Gluconobacter) or the microorganism of Saccharomyces (Saccharomyces).Specifically
Ground, can select to belong to the microorganism of Cryptococcus, more specifically, described microorganism can be selected from: cryptococcus albidus
(Cryptococcus albidus), autochthonal cryptococcus (Cryptococcus humicolus), raw cryptococcus
(Cryptococus terreus) and fingernail cryptococcus (Cryptococcus uniguttulatus).
In another example, enzyme E3Can be phosphorous acid dehydrogenase (E3b) or hydrogenlyase (E3c).Serve as phosphorous acid
Dehydrogenase (E3b) or hydrogenlyase (E3c) the biology in source can be unrestricted, and can be microorganism or higher organism,
And microorganism such as antibacterial, fungus and yeast are suitable.
In an example, according to cell and the enzyme E of any aspect of the present invention1c、E2aAnd E3aWild-type cell compare
There is the expression of increase.In another example, according to the wild-type cell of the cell of any aspect of the present invention with following enzyme
Compare the expression with increase: E1c、E2aAnd E3b；E1c、E2aAnd E3c；E1c、E2bAnd E3a；E1c、E2bAnd E3b；Or E1c、E2bAnd E3c。
The teachings of the present invention be possible not only to use and have the most clearly (such as by title or accession number) or
The definite aminoacid impliedly mentioned or the biomacromolecule of nucleotide sequence realize, and can use the variant of such sequence
Realize.Term used herein " variant " comprise be respectively provided with at least 70% with reference to aminoacid or nucleotide sequence, 75%, 80%,
85%, the aminoacid of 90%, 92%, 94%, 95%, 96%, 97%, 98 or 99% homogeneity or nucleotide sequence, the most preferably except merit
Can be lacked, put by aminoacid beyond (example glairy catalysis activity) or the folding of molecule or required those aminoacid of structure
Change or be inserted into replacement, or essential amino acids is replaced with the molecule reaching canonical sequence or deriving from it in the way of conservative
The retained effect of biological activity.Prior art includes may be used for two nucleic acid provided of comparison or aminoacid sequence and meter
Calculate the algorithm of homogeneity degree, see Arthur Lesk (2008), Thompson et al., 1994, and Katoh et al.,
2005.Term " variant " synonymously and is interchangeably used with term " homologue ".Such variant can be prepared as follows: at ammonia
Base acid or nucleotide sequence and comprise such macromole or its variant fusant in introduce disappearance, insert or replace.One
In individual example, about aminoacid sequence, term " variant ", in addition to comprising above sequence iden, also comprises and each reference
Or wild-type sequence compares the aminoacid sequence comprising the change of one or more conserved amino acid, or comprise coding containing one or
The nucleotide sequence of the aminoacid sequence of multiple conserved amino acids change.In an example, aminoacid sequence or nucleotide sequence
Term " variant ", in addition to comprising above degree of sequence identity, also comprises described aminoacid sequence or nucleotide sequence is respective
Arbitrarily active part and/or fragment, or the active part of encoding amino acid sequence and/or any nucleotide sequence of fragment.Herein
The term " active part " of middle use represents such aminoacid sequence or nucleotide sequence: it is respectively smaller than full length amino acid sequence
Or coding is less than full length amino acid sequence, the aminoacid sequence of wherein said aminoacid sequence or described coding retains its respectively
At least some of essential biologically active.The active part of such as protease and/or fragment can peptide bonds in hydrolyzed peptide.
Phrase used herein " retains at least some of its essential biologically active " and refers to, subject amino acid sequence have exceed and
It is different from the biological activity of background activity and characterizes the kinetic parameter of described activity, more specifically kcatAnd KMPreferably exist
With reference in the 3 of value, 2 or 1 orders of magnitude that molecule shows relative to specific substrates.Similarly, " variant " bag of term nucleic acid
Containing such nucleic acid, its complementary strand preferably hybridizes with reference or wild-type nucleic acid under high stringency conditions.Technical staff can hold
Change places and determine enzyme E1、E2And/or E3, described enzyme will can prepare alkene according to any aspect of the present invention from fatty acid.
There iing H2O2In the presence of and there is no H2O2In the presence of (i.e. having enzyme E2In the presence of and substitute regulation albumen) according to this
Being diagrammatically shown in chemical reaction route 1 of the difference of the reaction occurred in the cell of any aspect of invention.Specifically, changing
Learn in reaction scheme 1 (A), it is shown that by enzymatic oxidation reduction-cascade that saturated fat acid decarboxylation is terminal olefin.Show
Electronics is transferred to OleT from hydride donor (such as glucose, formates or phosphite) via CamAB, and described OleT is with greatly
Gas O2For cost catalysis fatty acid oxidation decarboxylation for having at C3-C21In the range of the terminal olefin of chain length.The pair detected
Product shows in bracket.In chemical reaction route 1 (B), it is shown that having H2O2In the presence of same reaction.
Chemical reaction route 1:OleT is to the oxidative deamination without branch's satisfied fatty acid.
The preciseness of hybridization is readily determined by those of ordinary skill in the art, and it is long to be typically to depend on probe
The experience of degree, wash temperature and salinity calculates.It is said that in general, the longer probe higher temperature of needs could be the most involutory,
And shorter probe needs relatively low temperature.Hybridization often relies on when in being present in less than the environment of their fusion temperature
The ability that the DNA of degeneration is the most involutory with complementary strand.Expectation degree of homology between probe and interfertile sequence is the highest, can
Relative temperature with use is the highest.So, the highest relative temperature will be tended to make reaction condition more rigorous, and relatively low
Temperature make reaction condition the most rigorous.About additional detail and the explanation of preciseness of hybridization, see F. M.
Ausubel (1995).Those skilled in the art can follow at handbook " The DIG System Users Guide for
Filter Hybridization ", Boehringer Mannheim GmbH, Mannheim, Germany, 1993 and
Liebl et al., 1991(differentiate DNA sequence about how by means of hybridization) in the guidance that is given.In an example, will
High stringency conditions is applied to any hybridization, the most only hybridizes when probe and target sequence have 70% or more homogeneity.With target sequence
Row have the probe of relatively low homogeneity degree and can hybridize, but such crossbred is unstable, and will be at high stringency conditions
Under remove in washing step, such as by salinity being reduced to 2 x SSC, or, optionally and subsequently, be reduced to 0,5
X SSC, and temperature with incremental priority be of about 50 DEG C-68 DEG C, about 52 DEG C-68 DEG C, about 54 DEG C-68 DEG C, about
56 DEG C-68 DEG C, about 58 DEG C-68 DEG C, about 60 DEG C-68 DEG C, about 62 DEG C-68 DEG C, about 64 DEG C-68 DEG C, about 66
℃- 68℃.In an especially preferred embodiment, temperature is about 64 DEG C-68 DEG C or about 66 DEG C-68 DEG C.May
Salinity is adjusted to 0.2 x SSC or even 0.1 x SSC.Can separate with reference to or wild-type sequence has at least 70%,
80%, the polynucleotide passage of the homogeneity degree of 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%.Herein
" homologue " of the term nucleotide sequence used represents, according to the degeneracy of genetic code, encodes identical with reference to nucleotide sequence
Any nucleotide sequence of aminoacid sequence.
Technical staff can easily measure enzyme E1、E2And E3In each of activity.Such as, in order to determine cell
In E1Expression whether increase, technical staff can use at Liu et al., 2014, Rude M.A, 2011,
Mensuration disclosed in Schallmey, A., 2011 etc..Such as, in order to determine the E in cell2Expression whether increase, technology
Personnel can use at Scheps, D, 2011, Roome et al., the mensuration disclosed in Schallmey et al. etc..Use at least
Mensuration disclosed in Cartel et al., can measure the E in cell3Expression, no matter it is to increase or declines, described
Formate dehydrogenase enzyme assay (via NAD (P)+reduction) is defined as the change of the absorbance at 340 nm by mensuration.Technology
Other well-known method that personnel will be readily able in discernibility territory, described method may be used for measuring in the present invention
Cell in the expression of enzyme that uses.
The cell of any aspect according to the present invention can have being dropped by beta oxidation of reduction compared with wild-type cell
Solve the ability of fatty acid.Specifically, the Fatty acid degradation activity of reduction can be and wild-type cell compared with wild-type cell
Compare selected from least one following enzyme reduce express result: ethylene reductase (FadE) (E6) (EC:
1.3.99.-), enoyl-CoA hydratase (FadB) (E7) (EC 4.2.1.17), (R)-3-hydroxyl ethylene reductase
(FadB) (E8) (EC 1.1.1.35) and 3-ketoacyl base CoA thiolase (FadA) (E9) (EC:2.3.1.16)。
Term used herein " has the Fatty acid degradation ability of reduction " and refers to, each cell degradation fatty acid is (special
Those absorbed from environment) speed less than having comparable cell or the wild-type cell of normal fatty acids degradation capability
Speed under the same conditions.In an example, because at least one encodes the gene of the enzyme related in beta oxidation approach
Disappearance, suppress or inactivate, the Fatty acid degradation of such cell is relatively low.In an example, with various wild-type microorganisms
In same enzyme activity under the conditions of comparable compare, at least one enzyme related in beta oxidation approach is the most suitable to be incremented by
Sequence has lost 5%, 10%, 20%, 40%, 50%, 75%, 90% or 99% activity.Those skilled in the art may know may be used for
The various technology of the activity of such enzyme in the gene of disappearance codase or reduction cell, such as by exposing cells to radiation
Property, accumulate or screen the mutant obtained subsequently, the location of point mutation introduces, or the chromosomal integration gene of encoding active enzyme
Knock out, as described in Sambrook/Fritsch/Maniatis (1989).Furthermore it is possible to the sub-FadR of process LAN Transcription inhibition
The repressed effect of expression of the enzyme reaching to relate in beta oxidation approach (Fujita, Y., et al., 2007).Make herein
Phrase " disappearance of gene " refer to, encode the nucleotide sequence of described gene through modifying so that by described gene code
The expression of active polypeptide reduces.For example, it is possible to following missing gene: remove in the catalysis activity comprising coded polypeptide in framework
A part for the sequence of the sequence of the heart.It is alternatively possible to change ribosome binding site so that correspondence no longer translated by ribosome
RNA.The standard test described in zymetology textbook (such as Cornish-Bowden, 1995) such as is used to measure by living cells
The activity of the enzyme expressed, belongs to the conventional technical ability of those skilled in the art.
The degraded of fatty acid is realized by a series of enzymic catalytic reactions.First, fatty acid passes through transport/acyl group-work
Changing mechanism and absorbed and cross-cell membrane shifts, described mechanism includes that what at least one outer membrane protein and a kind of inner membrance combined has
The albumen of fatty acid CoA ligase activity, is referred to as FadL and FadD/FadK in the case of escherichia coli respectively.Carefully
Intracellular, fatty acid to be degraded suffers to be catalyzed other enzyme reacted of beta oxidation approach.First intracellular step relates to acyl group
Coenzyme A changes into enoyl CoA by ethylene reductase, and the latter is referred to as FadE in the case of escherichia coli.Permissible
Measure the activity of ethylene reductase as described in prior art, such as, pass through spectrophotometer method at 340 nm 100
MM MOPS(pH 7.4), 0.2 mM enoyl CoA, 0.4 mM NAD+The concentration of middle monitoring NADH.The enoyl CoA obtained leads to
Cross enoyl-CoA hydratase/(R)-3-hydroxyl ethylene reductase (being referred to as FadB and FadJ in escherichia coli) catalysis
Hydration and oxidation change into 3-ketone acyl-CoA via 3-hydroxyl acyl-CoA.Can (example as described in prior art
As about as described in FadE) lived by spectrophotometer method mensuration enoyl-CoA hydratase/3-hydroxyl ethylene reductase
Property, the more specifically formation of product NADH.Finally, 3-ketoacyl base CoA thiolase FadA and FadI in escherichia coli urges
Change the cracking of 3-ketone acyl-CoA, to produce S-acetyl-coenzyme-A and to shorten the input acyl-CoA of 2 carbon atoms.Can be as
In the prior art (such as at Antonenkov, V., et al., in 1997) described mensuration ketoacyl base CoA thiolase
Activity.
Phrase used herein " there is the cell of the Fatty acid degradation ability of reduction " represent have reduction absorption and/
Or the cell of the ability of degraded fatty acid (particularly have at least 8 carbochains those).Cell can be reduced in a different manner
Fatty acid degradation ability.Specifically, according to the cell of any aspect of the present invention have compared with its wild type reduction
The activity of the enzyme related in beta oxidation approach.Term used herein " enzyme related in beta oxidation approach " represents such
Enzyme: it is the most mutual with the fatty acid or derivatives thereof formed as a part for Fatty acid degradation by beta oxidation approach
Effect.Beta oxidation approach comprises the anti-of a series of coenzyme A ester realizing the fatty acid that convert fatty acids is S-acetyl-coenzyme-A and shortening
Should.The enzyme related in beta oxidation approach, by fatty acid or derivatives thereof is identified as substrate, can convert it to conduct
The part of beta oxidation approach and the metabolite that formed.Such as, ethylene reductase (EC 1.3.99.-) is at beta oxidation
The enzyme related in approach, because it interacts with fatty acid coa A and fatty acid coa A ester is changed into enoyl CoA, after
Person is the metabolite formed as a part for beta oxidation.In another example, term used herein is " at beta oxidation
The enzyme related in approach " comprise selected from following any polypeptide: ethylene reductase (EC 1.3.99.-), enoyl CoA
Hydrase (EC 4.2.1.17), 3-hydroxyl ethylene reductase EC 1.1.1.35) and 3-ketone-Acyl-CoA thiolase
(EC 2.3.1.16).Acyl-CoA synthetase (EC 6.2.1.1) can be catalyzed the coenzyme A ester that convert fatty acids is fatty acid,
The most such molecule, wherein the functional group OH of carboxyl is replaced by-S-CoA, and described fatty acid is introduced beta oxidation approach.Example
Such as, polypeptide FadD and FadK in escherichia coli (accession number respectively: be BAA15609.1 and NP_416216.4) that acyl group is auxiliary
Enzyme A dehydrogenase.In an example, term used herein " ethylene reductase " can be can catalyzing acyl auxiliary
Enzyme A changes into the polypeptide of enoyl CoA (as a part for beta oxidation approach).Such as, the polypeptide FadE in escherichia coli
(accession number: BAA77891.2) can be ethylene reductase.Term used herein " enoyl-CoA hydratase " is also
Being referred to as 3-hydroxyl ethylene reductase, expression can be catalyzed enoyl CoA and change into 3-ketone acyl-coenzyme A(by hydration
And oxidation, as a part for beta oxidation approach) polypeptide.Such as, polypeptide FadB and the FadJ (accession number in escherichia coli
It is enoyl-CoA hydratase respectively: BAE77457.1 and P77399.1).Term used herein " ketoacyl base coenzyme A
Thiolase " can represent such polypeptide: it can be catalyzed the cracking of 3-ketone acyl-CoA, thus produces that to shorten 2 carbon former
The acyl-CoA of son and S-acetyl-coenzyme-A, as the final step of beta oxidation approach.Such as, the polypeptide FadA in escherichia coli and
FadI is (accession number respectively: YP_491599.1 and P76503.1) be ketoacyl base CoA thiolase.
Term used herein " contact " refer to realize any aspect according to the present invention in aqueous aminoacid,
Directly contact between fatty acid and/or cell.Such as, cell, aminoacid and fatty acid can not be (the most inorganic by barrier
Film) in the different compartments that separates.If aminoacid or fatty acid are solubilities and can be absorbed by cell or can be across biology
Membrane diffusion, can add the cell of any aspect according to the present invention in feed solution simply by it.It solubility not
In the case of foot, it can be dissolved in suitable organic solvent before adding in aqueous solution.Those skilled in the art are led to
Cross and add suitable organic solvent and/or polar solvent can prepare the water-soluble of the aminoacid with not enough solubility or fatty acid
Liquid.Such solvent can provide with the form comprising the organic facies of liguid organic solvent.In an example, when at 25 DEG C and
When normal atmosphere is liquid, organic solvent or liquid can be regarded as mutually.In another example, fatty acid can be with fatty acid
The form of ester (the most various methyl ester or ethyl ester) provides.In another example, compound and catalyst can be made in vitro to connect
Touching, i.e. with that be generally enriched with or even purification state, or can contact in position, i.e. they are as one of cellular metabolism
Divide and produce, and subsequently in intracellular reaction.
Term " aqueous solution " or " culture medium " comprise any aqueous solution (mainly water) as solvent, and described solvent can
For shape that is that temporarily, at least the cell of any aspect according to the present invention is maintained metabolic activity and/or that can survive
State, and comprise (if this is if necessary) any extra substrate.Those skilled in the art know the preparation of numerous aqueous solutions,
Described aqueous solution is frequently referred to as the culture medium that may be used for maintaining cell of the present invention, the such as LB for escherichia coli and cultivates
Base.Advantageously using minimal medium as aqueous solution, described minimal medium the most suitably simplifies the culture medium of composition, its with
Complex medium compare only comprise the essential salt of state that is that cell is maintained metabolic activity and/or that can survive and
The minimal set of nutrient, to avoid the unnecessary pollution to product of undesirable by-product.Such as, M9 culture medium can serve as
Minimal medium.
According to any aspect of the present invention, fatty acid is added the water-soluble of the cell that comprises any aspect according to the present invention
In liquid.This step can not only include making fatty acid and described solution brought into temporary contact, and in fact with the presence of described cell
Lower incubation fatty acid be enough to allow the time that oxidation reaction and other possible downstream reaction occur, and for example, at least 1,2,4,5,10
Or 20 hours.The temperature selected must make the cell of the present invention keep catalysis active and/or metabolic activity, such as 10-42 DEG C,
Preferably 30-40 DEG C, specifically, in the case of described cell is Bacillus coli cells, 32-38 DEG C.
In an example, can be included in after step (a) according to the method for any aspect of the present invention or and step
A " the immiscible organic solvent of water " is simultaneously added cell and the mixing of fatty acid of any aspect according to the present invention by ()
Another step in thing.Those skilled in the art know numerous water that any aspect according to the present invention can use and can not mix
Molten organic solvent.In an example, term used herein " the immiscible organic solvent of water " represents suchization
Compound: it comprises at least 2 carbon atoms and having and is clearly separated with described aqueous phase 25 DEG C of formation in the presence of aqueous liquid phase
The trend of another liquid phase.Separate can be Continuous Liquid Phase or emulsion mutually.In an example, art used herein
Language " water is immiscible " represents that liquid compound is insoluble in the trend of water.In another example, art used herein
Language " water is immiscible " refers to, so named compound has specific pH-value (J Sangster, 1997), described pH-
The decimal log of value more than 0,0.5,1 or 2.The example of the immiscible organic solvent of water is including, but not limited to selected from following
The immiscible solvent of water: at the alkane that room temperature is the substituted of liquid and straight chain, cycloalkane, cycloolefin, aryl compound, fat
Fat acid, fatty acid ester, alcohol, heterocycloalkane, heterocyclic alkene and heteroaryl compound.The immiscible organic solvent of water can comprise
Exceed a kind of organic solvent.In a preferred embodiment, " water is immiscible organic in term used herein use
Solvent " " extraction " product refers to, makes that the aqueous solution of the cell comprising any aspect according to the present invention is immiscible with water to be had
Machine solvent contact long enough with allow described product enter comprise the immiscible solvent of water mutually in.Subsequently, can make to comprise
Separating with aqueous solution of the immiscible organic solvent of water, such as by distilling or passing through decant.
In an example, the immiscible organic solvent of water can be fatty acid or its ester, in an example, described
Fatty acid is by formula CH3 - (CH2)xCOORs represents, wherein x is 8,9,10,28, and more preferably 12 or more than 12, and its
Middle Rs is H or alkyl, and described alkyl can be methyl or ethyl.In an example, the immiscible organic solvent of water is permissible
Being unsaturated fatty acid, it has the fatty acid of carbon-to-carbon double bond at the position 9 of carbochain, or has 12 or more carbon atom.
In another example, the immiscible organic solvent of water can be oleic acid or caproic acid or methyl laurate.Water is immiscible
The volume of organic solvent makes it be directly separated with aqueous solution.In an example, the volume of the immiscible organic solvent of water
It is 2-98%, 5-95%, 10-40% or 20-30% of the combination cumulative volume of aqueous solution and the immiscible organic solvent of water.
Specifically, can be NAD+/NADH according to the cofactor of the method for any aspect of the present invention.More specifically, institute
The method of stating farther include the cofactor NAD (P) for regenerating consumption+coupling cofactor regeneration method.Described coupling auxiliary because of
Sub-renovation process also includes the regeneration of the glucose of sacrifice of consumption, formates, phosphine etc..
Accompanying drawing explanation
The following drawings and limiting examples further illustrate the present invention, permissible from the following drawings and limiting examples
Understand other embodiments of the present invention, aspect and advantage.
Fig. 1 be derived from OleT-CamABFDH to the chromatogram of the conversion of enanthic acid (cascade. a=CO2; b = EtOH; c
=1-hexene;D=MIBK (derived from EtOH).Compound is manually injected into GC-MS chromatograph from reaction vessel head space
In.
Fig. 2 is the later chromatogram of analytical standard product of manual GC with Headspace-MS injection 1-hexene.
Fig. 3 is the figure of the GC-MS wave spectrum of the peak c in Fig. 1 corresponding with 1-hexene (84.1 g/mol).
Fig. 4 is the figure of the GC-MS wave spectrum of the peak c in Fig. 2 that the analytical standard product (84.1 g/mol) with 1-hexene are corresponding.
Fig. 5 is from the OleT-CamAB-FDH cascade color to obtaining after the ion extraction of the ion 84 of the conversion of enanthic acid
Spectrogram.
Fig. 6 is the peak area using the ion 84 the extracted calibration trace about the manual GC with Headspace-MS injection of 1-hexene.
Fig. 7 is the figure of the new reaction scheme of the alpha-olefin (such as 1-propylene and 1-butylene) for capturing volatile.To contain
The little impinger having 10 ml 20 mM Br2/DCM solution be placed on the top of flask serve as unique gas outlet and trapping α-
Olefin product.The analytical standard product using 1-heptene successfully confirm the functional of this system.Route map 2 shows and waves
The derivatization of the property sent out alpha-olefin and the concept of trapping.
Fig. 8 is the GC-FID chromatogram being produced 1-butylene by OleTCamAB-FDH cascade from valeric acid.1=dust measures
Device solution (DCM/Br2)；2=convert the content of impinger solution after valeric acid 24 h with OleT-CamAB-FDH cascade
Thing.The analytical standard product of 3=1,2-dibromobutane；4=impinger solution after valeric acid converts 24 h under not having OleT
Content.A=solvent peak (DCM)；B=1,2-dibromobutane;C=from the impurity of DCM solvent.
Fig. 9 is the GC-FID chromatogram being produced 1-propylene by OleT-CamAB-FDH cascade from valeric acid.1=1,2-bis-
The analytical standard product of N-Propyl Bromide；2=convert in valeric acid 24 h impinger solution later with OleT-CamAB-FDH cascade
Tolerant.3=convert the content of impinger solution after butanoic acid 24 h with OleT-CamAB-FDH cascade；4=dust is surveyed
Determine device solution (DCM/Br2)；A=solvent peak (DCM)；B=1,2-dibromopropane;C=1,2-dibromobutane;D=come
Impurity from DCM solvent.
Embodiment
Disclosed preferred embodiment, it is as it will appreciated by a person of ordinary skill, can be designed, construct
Or the change in terms of operation or amendment, without deviating from the scope of claim.Such as, these changes are intended to by the model of claim
Enclose and contain.
Embodiment 1
The clone of OleT, expression and quantitatively
All chemical substances derive from Sigma Aldrich.Spinach ferredoxin, spinach ferredoxin reductase, derive from cattle
(NADPH is dependent, clarification for the catalase of liver, lysozyme, the cytochrome c deriving from cor bovinum and glucose dehydrogenase
Commercial source) derive from Sigma Aldrich.Hydrogenlyase (NADH is dependent) derives from Evocatal.According to standard scheme
Preparing phosphorous acid dehydrogenase (PDH) (Dudek, H.M., 2013), plasmid derives from M. Fraaije (Groningen).
OleT is ordered, as the optimum expression codon in escherichia coli from Life Technologies
The synthetic gene optimized.The construct of synthesis is cloned existed into pET28a expression vector by restriction/connection (NdeI and XhoI)
N-end His6-label downstream (pET28a-OleT), then escherichia coli SHuffle T7 bacterial strain (New is entered in chemical conversion
England Biolabs).By bacterium colony PCR, restriction analysis and order-checking, the clone being proved to be successful.Will be containing pET28a-
The cell of OleT is supplementing 50 g mL-1Overnight incubation in lysogeny meat soup (LB) culture medium of kanamycin (140 rpm,
37 DEG C) as pre-culture.According to disclosed scheme (Nazor, J, 2009), by 2 mL pre-culture are transferred into 200
In the fabulous meat soup of mL (terrific broth) (TB) culture medium, it is achieved the expression of OleT.Temperature under 25 DEG C and 140 rpm shakes
After educating 20 h, it is achieved the effective expression of OleT.Cell is separated with expression culture medium by centrifugal, and by precipitate at-20 DEG C
Store 24 h.Freezing cell precipitate is resuspended in purification buffer (KPi; 0.1 M; pH 7.0;20% glycerol,
0.3 M KCl;50 mM imidazoles) in.Add lysozyme (1 mg mL-1), subsequently at 37 DEG C of incubation 1 h.Finally use ultrasonic broken
Millstone passes through sonication (1 min, 30% amplitude) smudge cells.Make pellet cell debris by centrifugal, and split acellular
Solve thing and press through 0.45 m filter to remove remaining granule.The acellular lysate filtered is loaded into and there is ultraviolet inspection
Survey on the His-Trap post of Biorad FPLC pumping system connection of device.According to Matsunaga et al., the scheme purification of 2001
OleT, but use 400 mM (rather than 200 mM) imidazoles for final elution step.At the dialysis buffer liquid with report
During the OleT of (KPi, 0.1 M, pH 7.0,20% glycerol) dialysis purification, a large amount of albumen form precipitation (only 1-2 M
The activated protein concentration of OleT is retained).In order to remove imidazoles and the prevention precipitation of remnants, at the phosphorus containing 300 mM KCl
Phthalate buffer (KPi, 0.1 M, pH 7.0,20% glycerol) is dialysed.Protein cleavage thing is loaded Dialysis tubing fiber
In element film (14 kDa cutoffs, Sigma Aldrich, Steinheim, Germany) bag filter, and at 300 ml dialysis buffers
Dialyse in liquid under 4 DEG C and continuous stirring 3 times (3 x 12 h).It is macroscopic heavy not occur in dialysis procedure
Form sediment, and generally yield the active P450 concentration of 10 M.By record CO difference wave spectrum, determine acellular lysate or pure
The concentration of the active P450 albumen in the OleT changed.
The clone of CamAB system, expression and quantitatively
According to the disclosed Plasmid Constructs using report and the scheme (Schallmey, A., 2011) of escherichia coli host,
Carry out the expression of CamA and CamB (CamAB).
Product extraction, fatty acid and the derivatization of hydroxy acid
By adding 100 L 5 N HCl, cancellation enzyme reaction (1 mL scale).The EtOAc containing 0.1%1-decanol with 500 L makees
For internal controls, perform substrate and the extraction of product.By organic facies through anhydrous Na2SO4It is dried.By by organic facies and MeOH
(2.5:1.5 v/v) mixes, and supplements 5-15 L 2 M TMSCHN subsequently2(trimethyl silyl Azimethylene. is in ether
Solution), it is achieved carboxylic acid (fatty acid and hydroxy acid) is to the derivatization of corresponding methyl ester.By mixture 25 DEG C and 750 rpm temperature
Educate 30 min, be then injected in GC-FID or GC-MS.Use same approach, perform the conversion from short chain FA (C12-C9)
Product and the extraction of substrate and derivatization, but the most all carry out on ice preventing undesirable volatile products
Loss.
Preparation for the sample that GC with Headspace-MS analyzes
The product deriving from the FA substrate of the chain length with C22 to C10 scope is above separated at HP5 post (Programm), and leads to
Cross GC-FID or GC-MS to detect.Using the product (1-octene is as product) of the conversion from n-nonanoic acid of extraction at DB1702
Post (Programm) is upper to be separated, and is detected by GC-FID.Substrate processed as above and the real standard of terminal olefin
Product, and be used for differentiating and preparing calibration trace as reference substance.By entering in GC-MS from bottle head space manual injection, complete to wave
The detection of the short chain terminal olefin (1-butylene/1-propylene [in carrying out] is to 1-heptene) of the property sent out, in order to prevent the loss of product, will
Bottle containing reactant mixture PTFE diaphragm seal.After conversion, by the bottle closed and 10 ml syringes (TYPE)
Rise and heat 10 min at 80 DEG C.From head space, 2-9 l volume is injected into GC-MS chromatograph without shunting, and at HP5 post
(Programm) analyte is separated on.In an identical manner 4 DEG C and use 5%DMF as cosolvent, preparation 1-amylene, 1-oneself
Alkene and the calibration trace of 1-heptene.
Embodiment 2
With the cascade of CamAB-OleT oxidoreduction and the O as oxidant2Convert FA
One optimized purification schemes allows to improve the production (10-20 from 400 mL culture fluid of the OleT of activity form
M), thus avoid dialysis (ESI) during albumen precipitation.Use antibacterial CamAB (putidaredoxin；I class) conduct
Electron transfer system (Koga H., 1989 and Roome P.W., 1983) (chemical reaction route 1).Preliminary experiment confirms,
OleT can accept the electronics from CamAB, thus allows to use O2As sole oxidizing agent by stearic acid decarboxylation, and control reaction
It is not result in that spawn forms (table 1).It moreover has been found that relatively low CamAB concentration is the suitableeest for higher conversion.
After the complete oxidation of 1 mM NADH, the scheme according to manufacturer uses high-sensitive HRP/ABTS to measure (Sigma
Aldrich) can detect and be formed without H2O2(via O2Reduction and formed), further instruction is from CamAB's to OleT
Direct electron transfer, and get rid of H2O2Potential inactivation to OleT.
Table 1: use O2/ CamAB or H2O2The catalysis of OleT during the decarboxylation of stearic acid and Palmic acid it is used for as oxidant
Characterize.
Reaction condition: 1 M OleT, 0.05 U ml-1 CamAB, 1200 U ml-1Catalase, 1 mM substrate,
2.5%EtOH, KPi buffer (pH 7.5,0.1 M).Plastics cuvette in room temperature and does not convert under stirring.
With the H as oxidant2O2Reaction contain only OleT, substrate, buffer and hydrogen peroxide.
* strong precipitation is observed.
1One of following component is excluded outside reactant: OleT, H2O2, CamAB, NAD (P) H or substrate.
Embodiment 3
FA is converted with the cascade of CamAB-OleT oxidoreduction and NAD (P) H regenerative system
Systematic difference based on glucose dehydrogenase (GDH) can provide conversion ratio (being 36% conversion ratio for 1mM stearic acid) and
TTN (for 10 mM stearic acid up to 389) is significantly increased, and stearic acid and Palmic acid have comparable conversion ratio.24 h
After response time, obtain 1.16 mM (0.27 g L-1) 1-heptadecene and 1 mM (0.21 g L-1) 1-15 carbon
The production concentration of alkene, but can not increase further.Therefore have studied NAD (P) the H regeneration as GDH and glucose realization
By-product and the inhibitory action of gluconic acid that formed, and have been found that the concentration of 10 mM can significantly reduce the OleT productivity (28%
Decline).Based on phosphorous acid dehydrogenase (PDH;NADPH is dependent) (Dudek, H.M., 2013 and Vrtis J.M.,
2002) with based on hydrogenlyase (FDH;NADH is dependent) alternative system of (Busto E., 2014) is proved to be more
Effective: to respectively obtain 2.6 mM (0.62 g L-1) and 3.1 mM (0.75 g L-1) 1-17 carbon from 5 mM stearic acid
Alkene (being 52% and 62% conversion ratio respectively), so that producing the highest TTN value with above-mentioned regenerative system (be respectively
1739 and 2096).Compared with in the past disclosed full cell effect system, the system that this FDH drives allow 8 h response time with
After for the alpha-olefin of 42.5 mg L-1 h-1 the product titre of high 6 times and high 21 times volumetric productivity (relative to
98 mg L-1 in 48 h) (table 2).
Table 2: use O2When using different oxidoreduction gametophyte system as oxidant, OleT is to stearic decarboxylation.
Reaction condition: 0.05 U ml-1 CamAB, 1200 U ml-1Catalase, 12 U ml-1GDH or 2 U ml-1
GDH or 0.2 U ml-1PDH, 100 mM D-Glucoses or 100 mM ammonium formates or 100 mM sodium phosphites, 5 mM are stearic
Acid, 2.5%EtOH, KPi buffer (pH 7.5,0.1 M) and 200 M NAD (P) H.1 in the vial closed
Ml scale carries out reacting 24 h under room temperature and 170 rpm are shaken.
aFdr/Fdx naturally occurs in escherichia coli, and allows electronics to be transferred to OleT from NAD (P) H.
bReactant contains the cryodesiccated lysate that 53 mg express the cell of OleT.
Embodiment 4
Use FDH-CamAB-OleT oxidoreduction-cascade decarboxylation to fatty acid (FA).
By FA chain length is become C22 from C3, further study the substrate spectrum of OleT.Except the standard scheme in room temperature
In addition, also have studied this reaction to prevent the loss of high volatile short chain alpha-olefin at 4 DEG C, this can cause being surprisingly high
Activity level (table 3).Can be corresponding alkene by short FA decarboxylation first, cover the gamut from C11 as little as C4.Make us
Interested, the conversion of short chain FA (< C10) can be identified from strong " smell of petrol " of reaction tube release.Due to short-chain olefin
High volatility, carry out product postprocessing at 4 DEG C.Yield is strongly dependent on reaction temperature and substrate chain length, at below C18
It is remarkably decreased (from stearic maximum production concentration 2.45 mM of 5 mM) at room temperature reaction, and C12 is seemingly at 4 DEG C
Optimal substrate (from the lauric 2.53 mM products of 5 mM).By GC-MS to the reactant from short chain FA (C8-C5)
Headspace analysis confirms the formation of various alpha-olefin, thus allows to obtain 1-heptene, 1-by biotechnology OleT for the first time
Hexene and 1-amylene and 1-butylene.
Table 3: use FDH-CamAB-OleT oxidoreduction-cascade by FA decarboxylation.
Reaction condition: use 3 μMs of OleT, 6 μMs of OleT(for substrate C12-C3) perform substrate C22-C14 conversion.Institute
Respond mixture and contain 0.05 U ml-1 CamAB, 1200 U ml-1 catalases, 2 U ml-1 FDH, 100 mM first
Acid ammonium, 5%EtOH, 10 mM substrates, KPi buffer (pH7.5,0.1 M) and 200 μMs of NADH.Having as cosolvent 5%
The conversion of substrate C8, C7 and C6 is carried out in the presence of DMSO.Make GC with Headspace-MS injection by hand, it is achieved the inspection of short chain terminal olefin
Survey and quantitative.In 1 ml scale and 170 under the vial (RT sample/24 h) closed or stirring (4 DEG C of sample/72 h)
All conversions are carried out under rpm shake.
* the conversion ratio relative to C18/only GC-area.
N. i.=do not study.
Embodiment 5
The discriminating of the 1-hexene that OleT produces from enanthic acid is with quantitative
OleTCamAB-FDH reaction cascade is used to carry out the conversion of enanthic acid as described in example 4.As shown in FIG. 1 may be used
The decarboxylation of enanthic acid is carried out by ground.
The analytical standard product using 1-hexene confirm the formation of target product.Analytical standard product are at identical retention time eluting
(2.617 min；Fig. 1 and 2, peak c) also show the m/z pattern (Fig. 3 and 4) identical with the product that OleT is formed.
In the range of 0.05-2 mM, correspondingly prepare the calibration trace of 1-hexene.Due to 1-hexene and CO2Peak with EtOH
(Fig. 1, peak a, b and c) use the ion extraction pattern of GC-MS to produce reliable calibration trace for area strong overlapping.Own for 1-
Alkene, uses characteristic ionic 84 as shown in FIG. 5 for quantitatively.CO2Peak areas is not all interfered with EtOH.This can
To be seen by comparison diagram 1 and 5, it allows to make GC with Headspace-MS injection by hand carry out the reliable of 1-hexene and linear quantitative (figure
6)。
For having all substrates of the chain length of C11 to C6, the manual head space injection being successfully executed in GC-MS.
The production concentration obtained is summed up in table 3.Converting of 10 mM enanthic acid allows the reliable landform of optimization further without reaction condition
Become at most 1.3 mM 1-hexenes.
Embodiment 6
1-butylene and the trapping of 1-propylene, derivatization and quantitatively
Initially use manual GC with Headspace-MS injection confirms 1-propylene and the generation of 1-butylene.Owing to using analytical standard product to 1-
Propylene and the quantitative of 1-butylene are not feasible, devise the height volatile short chain alpha-olefin derived from biocatalytic reaction
New trapping/derivatization system.Thus, the reaction unit (seeing the reaction condition in table 3) set up is amplified to 10 ml and (makes
With 25 ml double-neck flasks), and in device as shown in Figure 7, perform butanoic acid (C4) and the decarboxylation of valeric acid (C5).
Chemical reaction route 2: cascaded butanoic acid decarboxylation by OleT-CamAB-FDH, subsequently will with Br2 in impinger
Volatile 1-propylene derived is to produce 1,2-dibromopropane as final product.
Use 1,2-dibromobutane and 1, the analytical standard product of 2-dibromopropane, analyzed by GC-FID and GC-MS and obtain
Product.Owing to (macroscopic) gas is discharged, (OleT and FDH produces CO2) and strong DCM evaporation (lose after 24 h
About 70% volume), determine that the residual volume in impinger is to allow reliable product quantitative.Preparation 1,2-dibromobutane
With the calibration trace of 1,2-dibromopropane to allow the quantitative 1-propylene produced and 1-butylene (not shown).
Further, will be containing 1, the solution of 2-dibromobutane is concentrated into 700 l by dry air stream, and passes through1H-NMR
Being analyzed (Figure 11), it serves as OleT and forms another evidence of 1-butylene.Similarly, will be containing 1,2-dibromopropane molten
Liquid is concentrated into 700 l by dry air stream, and passes through1H-NMR is analyzed (Figure 16), and it serves as OleT and forms the another of propylene
One evidence.
The analytical standard product of 1,2-dibromobutane are1H NMR (300 MHz, CDCl3) δ 4.23 - 4.09 (m,
1H), 3.87 (dd, J = 10.2, 4.4 Hz, 1H), 3.66 (t, J = 10.1 Hz, 1H), 2.22 (dqd, J
= 14.6, 7.3, 3.3 Hz, 1H), 1.97 - 1.74 (m, 1H), 1.09 (t, J = 7.2 Hz, 3H)。
The analytical standard product of the 1,2-dibromopropane used are1H NMR (300 MHz, CDCl3) δ 4.34 - 4.20
(m, 1H), 3.87 (dt, J = 10.1, 5.0 Hz, 1H), 3.58 (t, J = 10.1 Hz, 1H), 1.85 (d,
J = 6.6 Hz, 3H)。
Perform control reaction (CamAB-FDH not having OleT cascades) to confirm only when reconstructing full stage in reaction vessel
The generation (Fig. 8 and 9) of 1-propylene and 1-butylene during connection.1,2-dibromobutane and 1,2-dibromopropane is confirmed also by GC-MS
Formation (not shown).For novel trapping strategy, may differentiate and quantitative 1-propylene and 1-butylene.Turning of 10 mM valeric acids
Change the formation causing 834 μMs of 1-butylene, and for the conversion of 10 mM butanoic acid, it is determined that 504 μMs of 1-propylene.At least one formula
Three parts of ground perform to be responded, and corresponding alpha-olefin is the unique product detected in impinger solution.
List of references
Belcher, J., et al., J Biol Chem, 2014. 289 (10): p. 6535-50.
Busto, E., et al., Chemistry, 2014. 20 (35): p. 11225-8.
Carter J.L.L., ChemBioChem 2014, 15, 2710 – 2718
Dudek, H.M., et al.. J. Biomol. Screen., 2013. 18 (6): p. 678-687.
Fujishiro T, J Biol Chem 2011, 286:29941–29950.
Hannemman F., Biochimica et Biophysica Acta 1770 (2007) 330–344
Koga, H., et al., J Biochem, 1989. 106 (5): p. 831-6.
Liu, Y., et al., Biotechnology for Biofuels, 2014. 7 (28).
Malca S.H., et al (2011) Biochimica et Biophysica Acta 1814 257–264
Matsunaga, I., et al., Archives of Biochemistry and Biophysics, 2001. 394
(1): p. 45-53.
Matsunaga I, FEBS Lett 2002, 528:90–94.
Nazor, J., et al., Protein Eng Des Sel, 2008. 21 (1): p. 29-35.
Roome, P.W., J Biol Chem, 1983. 258(4): p. 2593-8.
Rude, M.A., et al.. Appl Environ Microbiol, 2011. 77 (5): p. 1718-27.
Schallmey, A., et al., Appl Microbiol Biotechnol, 2011. 89 (5): p. 1475-85.
Scheps D, Org. Biomol. Chem. 9: 6727 -6733
Vrtis, J.M., et al., Chem Int Ed Engl, 2002. 41 (17): p. 3257-9.
Claims (12)
1. the microbial cell of at least one terminal olefin, wherein said cell warp can be produced from least one short-chain fatty acid
Cross genetic modification to comprise
-at least the first gene mutation, it increases the enzyme (E crossing oxygenase family selected from CYP152 compared with wild-type cell1)
Expression, and
-at least the second gene mutation, it increases at least one NAD (P)+oxidoreductase (E compared with wild-type cell2)
With the expression of corresponding regulation albumen,
Wherein said short-chain fatty acid is C4-C10Fatty acid.
Cell the most according to claim 1, wherein E1Selected from CYPSPα、(E1a)CYPBSB (E1b) and OleT (E1c)。
3. according to the cell described in any one in claim 1 or 2, wherein E1It is OleT (E1c) and have with SEQ ID NO:1
There is at least 60% sequence iden.
4. according to the cell described in any one in aforementioned claim, wherein said NAD (P)+oxidoreductase (E2) and right
The regulation albumen answered is:
(a) ferredoxin reductase (E2a) and ferredoxin；Or
(b) putidaredoxin reductase (E2b) and putidaredoxin.
5. according to the cell described in any one in aforementioned claim, wherein E2To have 60% sequence same with SEQ ID NO:2
Property, and described regulation albumen and SEQ ID NO:3 have 60% sequence iden.
6., according to the cell described in any one in aforementioned claim, wherein said cell comprises at least the 3rd base further
Because of sudden change, it increases at least one compared with wild-type cell can the enzyme (E of regeneration of NAD (P) H3) expression.
Cell the most according to claim 6, wherein said enzyme (E3) selected from glucose dehydrogenase, phosphorous acid dehydrogenase and first
Acidohydrogenase.
8., according to the cell described in any one in aforementioned claim, wherein said cell is further compared with wild-type cell
Comprise the Fatty acid degradation ability of reduction.
Cell the most according to claim 8, wherein reduces described by coding selected from the disappearance of the gene of following enzyme
Fatty acid degradation ability: fatty acid input enzyme, fatty acid CoA ligase, ethylene reductase, 2,4-bis-enoyl CoA
Reductase, enoyl-CoA hydratase and 3-ketoacyl base CoA thiolase.
10., according to the cell described in any one in aforementioned claim, wherein said cell is protokaryon or the eukaryotic cell such as low.
11. 1 kinds of methods producing at least one terminal olefin from least one short-chain fatty acid, described method includes
-make according to the recombinant microorganism cell described in any one in claim 1-10 and the medium comprising short-chain fatty acid
Contact.
12. are used for producing the purposes of at least one terminal olefin according to the cell described in any one in claim 1-10.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15156699 | 2015-02-26 | ||
| EP15156699.9 | 2015-02-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105925518A true CN105925518A (en) | 2016-09-07 |
Family
ID=52705945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610104399.7A Pending CN105925518A (en) | 2015-02-26 | 2016-02-25 | Olefin production |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9885060B2 (en) |
| EP (1) | EP3061827A1 (en) |
| KR (1) | KR20160104574A (en) |
| CN (1) | CN105925518A (en) |
| AR (1) | AR103794A1 (en) |
| BR (1) | BR102016003467A2 (en) |
| CA (1) | CA2937594A1 (en) |
| MX (1) | MX2016002478A (en) |
| RU (1) | RU2016106385A (en) |
| ZA (1) | ZA201601243B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112457412A (en) * | 2020-11-26 | 2021-03-09 | 浙江工业大学 | Artificial electron transfer system and application thereof in promoting P450 enzyme hydroxylation reaction |
| CN114854726A (en) * | 2022-06-21 | 2022-08-05 | 华南理工大学 | Mutant of fatty acid light decarboxylase McFAP and application thereof |
| CN115943179A (en) * | 2020-07-10 | 2023-04-07 | 意大利学院科技基金会 | Method for enhancing the biodegradability of polyolefin materials |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2944697A1 (en) | 2014-05-13 | 2015-11-18 | Evonik Degussa GmbH | Method of producing nylon |
| CN108473967B (en) | 2015-12-17 | 2022-03-29 | 赢创运营有限公司 | Genetically modified acetogenic cells |
| CN109072264A (en) * | 2016-05-04 | 2018-12-21 | 赢创德固赛有限公司 | unsaturated amino acid |
| WO2018019867A1 (en) | 2016-07-27 | 2018-02-01 | Evonik Degussa Gmbh | N-acetyl homoserine |
| EP4446416A2 (en) * | 2021-12-06 | 2024-10-16 | Centro Nacional de Pesquisa em Energia e Materiais - CNPEM | Chimeric enzyme and method for producing terminal alkenes |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102575265A (en) * | 2009-06-22 | 2012-07-11 | 焦耳无限科技公司 | Biosynthesis of 1-alkenes in engineered microorganisms |
| EP2647696A1 (en) * | 2012-04-02 | 2013-10-09 | Evonik Degussa GmbH | Method for aerobic production of alanine or a compound arising using alanine |
| US20140186905A1 (en) * | 2011-08-15 | 2014-07-03 | Evonik Degussa Gmbh | Biotechnological synthesis process of organic compounds with the aid of an alkl gene product |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102007060705A1 (en) | 2007-12-17 | 2009-06-18 | Evonik Degussa Gmbh | ω-aminocarboxylic acids or their lactams, producing, recombinant cells |
| WO2009085278A1 (en) * | 2007-12-21 | 2009-07-09 | Ls9, Inc. | Methods and compositions for producing olefins |
| DE102008002715A1 (en) | 2008-06-27 | 2009-12-31 | Evonik Röhm Gmbh | 2-hydroxyisobutyric acid producing recombinant cell |
| DE102008040193A1 (en) | 2008-07-04 | 2010-01-07 | Evonik Röhm Gmbh | Process for the preparation of free carboxylic acids |
| DE102009000661A1 (en) | 2009-02-06 | 2010-08-12 | Evonik Degussa Gmbh | Preparing (1S,5S)-2,6-dioxabicyclo-(3.3.0)-octan-4,8-dione, comprises oxidizing dianhydrohexitols or their corresponding hydroxy ketones with oxygen-containing gas in the presence of catalyst composition containing e.g. a nitroxyl radical |
| DE102009000662A1 (en) | 2009-02-06 | 2010-08-12 | Evonik Degussa Gmbh | Process for the preparation of aldehydes and ketones from primary and secondary alcohols |
| DE102009009580A1 (en) | 2009-02-19 | 2010-08-26 | Evonik Degussa Gmbh | Process for the preparation of free acids from their salts |
| DE102009046626A1 (en) | 2009-11-11 | 2011-05-12 | Evonik Degussa Gmbh | Candida tropicalis cells and their use |
| DE102010014680A1 (en) | 2009-11-18 | 2011-08-18 | Evonik Degussa GmbH, 45128 | Cells, nucleic acids, enzymes and their use, as well as methods for producing sophorolipids |
| DE102010015807A1 (en) | 2010-04-20 | 2011-10-20 | Evonik Degussa Gmbh | Biocatalytic oxidation process with alkL gene product |
| DE102010032484A1 (en) | 2010-07-28 | 2012-02-02 | Evonik Goldschmidt Gmbh | Cells and methods for producing rhamnolipids |
| EP2557176A1 (en) | 2011-06-15 | 2013-02-13 | Evonik Degussa GmbH | Enzymatic amination |
| DE102011110946A1 (en) | 2011-08-15 | 2016-01-21 | Evonik Degussa Gmbh | Biotechnological synthesis of omega-functionalized carboxylic acids and carboxylic acid esters from simple carbon sources |
| EP2602328A1 (en) | 2011-12-05 | 2013-06-12 | Evonik Industries AG | Method of Oxidation of alkanes employing an AlkB alkane 1-monooxygenase |
| EP2602329A1 (en) | 2011-12-05 | 2013-06-12 | Evonik Degussa GmbH | Biotechnological production of 3-hydroxyisobutyric acid |
| EP2607479A1 (en) | 2011-12-22 | 2013-06-26 | Evonik Industries AG | Biotechnological production of alcohols and derivatives thereof |
| EP2631298A1 (en) | 2012-02-22 | 2013-08-28 | Evonik Industries AG | Biotechnological method for producing butanol and butyric acid |
| PL2859105T3 (en) * | 2012-06-11 | 2018-07-31 | Shell Internationale Research Maatschappij B.V. | Enzymatic method for preparing hydrocarbons |
| EP2674489A1 (en) | 2012-06-15 | 2013-12-18 | Evonik Industries AG | Biotechnological 2-hydroxyisobutyric acid production |
| EP2733215A1 (en) | 2012-11-20 | 2014-05-21 | Evonik Industries AG | Process for producing alpha,omega-diols from alkanes or 1-alkanols employing a CYP153 alkane hydroxylase |
| US20140206057A1 (en) | 2012-12-31 | 2014-07-24 | Shell Oil Company | Novel yeast strains |
| EP2759598A1 (en) | 2013-01-24 | 2014-07-30 | Evonik Industries AG | Process for preparing alpha, omega alkanediols |
-
2016
- 2016-02-15 CA CA2937594A patent/CA2937594A1/en not_active Abandoned
- 2016-02-16 EP EP16155822.6A patent/EP3061827A1/en not_active Withdrawn
- 2016-02-18 BR BR102016003467A patent/BR102016003467A2/en not_active Application Discontinuation
- 2016-02-24 ZA ZA2016/01243A patent/ZA201601243B/en unknown
- 2016-02-25 KR KR1020160022425A patent/KR20160104574A/en not_active Withdrawn
- 2016-02-25 RU RU2016106385A patent/RU2016106385A/en not_active Application Discontinuation
- 2016-02-25 CN CN201610104399.7A patent/CN105925518A/en active Pending
- 2016-02-25 US US15/053,626 patent/US9885060B2/en not_active Expired - Fee Related
- 2016-02-25 MX MX2016002478A patent/MX2016002478A/en unknown
- 2016-02-26 AR ARP160100502A patent/AR103794A1/en unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102575265A (en) * | 2009-06-22 | 2012-07-11 | 焦耳无限科技公司 | Biosynthesis of 1-alkenes in engineered microorganisms |
| US20140186905A1 (en) * | 2011-08-15 | 2014-07-03 | Evonik Degussa Gmbh | Biotechnological synthesis process of organic compounds with the aid of an alkl gene product |
| EP2647696A1 (en) * | 2012-04-02 | 2013-10-09 | Evonik Degussa GmbH | Method for aerobic production of alanine or a compound arising using alanine |
Non-Patent Citations (2)
| Title |
|---|
| BELCHER, JAMES等: "Structure and Biochemical Properties of the Alkene Producing Cytochrome P450 OleTJE (CYP152L1) from the Jeotgalicoccus sp 8456 Bacterium", 《JOURNAL OF BIOLOGICAL CHEMISTRY》 * |
| LIU, YI等: "Hydrogen peroxide-independent production of alpha-alkenes by OleTJE P450 fatty acid decarboxylas", 《BIOTECHNOLOGY FOR BIOFUELS》 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115943179A (en) * | 2020-07-10 | 2023-04-07 | 意大利学院科技基金会 | Method for enhancing the biodegradability of polyolefin materials |
| CN112457412A (en) * | 2020-11-26 | 2021-03-09 | 浙江工业大学 | Artificial electron transfer system and application thereof in promoting P450 enzyme hydroxylation reaction |
| CN112457412B (en) * | 2020-11-26 | 2022-10-14 | 浙江工业大学 | An artificial electron transfer system and its application in promoting the hydroxylation of P450 enzymes |
| CN114854726A (en) * | 2022-06-21 | 2022-08-05 | 华南理工大学 | Mutant of fatty acid light decarboxylase McFAP and application thereof |
| CN114854726B (en) * | 2022-06-21 | 2023-09-19 | 华南理工大学 | Mutant of fatty acid light decarboxylase McFAP and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3061827A1 (en) | 2016-08-31 |
| MX2016002478A (en) | 2016-12-07 |
| KR20160104574A (en) | 2016-09-05 |
| ZA201601243B (en) | 2017-05-31 |
| AR103794A1 (en) | 2017-06-07 |
| CA2937594A1 (en) | 2016-08-26 |
| BR102016003467A2 (en) | 2016-09-20 |
| US9885060B2 (en) | 2018-02-06 |
| US20160326549A1 (en) | 2016-11-10 |
| RU2016106385A (en) | 2017-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105925518A (en) | Olefin production | |
| US10174342B2 (en) | Enzymatic hydroxylation of aliphatic hydrocarbon | |
| KR101883511B1 (en) | Production of alkenes by combined enzymatic conversion of 3-hydroxyalkanoic acids | |
| EP2304040B1 (en) | Production of alkenes by enzymatic decarboxylation of 3-hydroxyalkanoic acids | |
| JP5936601B2 (en) | Biocatalytic oxidation method using alkL gene product | |
| US10480016B2 (en) | Genetically engineered microorganisms for biological oxidation of hydrocarbons | |
| US10323232B2 (en) | Metabolically engineered methanotrophic, phototrophic microorganisms | |
| CA2888073A1 (en) | Process for producing alpha.omega-diols from alkanes or 1-alkanols employing a cyp153 alkane hydroxylase | |
| CA2861146A1 (en) | Process for oxidizing alkenes employing the pseudomonas putida gpo1 alkb monooxygenase | |
| JP2015517808A (en) | Method for producing medium chain ω-hydroxy fatty acid, α, ω-dicarboxylic acid, ω-amino fatty acid from long chain fatty acid by bioconversion | |
| CN108271388A (en) | Methionine produces | |
| CN110964757A (en) | Preparation method of glucaric acid | |
| Schüttmann et al. | Induction, characterization, and heterologous expression of a carotenoid degrading versatile peroxidase from Pleurotus sapidus | |
| CN109072264A (en) | unsaturated amino acid | |
| Gu et al. | Mid–long chain dicarboxylic acid production via systems metabolic engineering: progress and prospects | |
| US20150176041A1 (en) | Methods for producing dicarboxylic acids | |
| Luo et al. | Rapid gene cloning, overexpression and characterization of a thermophilic catalase in E. coli | |
| TW202307067A (en) | Method and system for storing energy in the form of biopolymers | |
| WO2021260022A1 (en) | Production of carbonyl compounds using cell surface display of oxidases | |
| JP2017112958A (en) | New aldehyde oxidase | |
| JP2010110233A (en) | Method for producing carbonyl compound using nitroreductase | |
| WO2018005934A1 (en) | Biological conversion of syngas to liquid chemicals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160907 |
|
| WD01 | Invention patent application deemed withdrawn after publication |